UBS Group’s Principal Contrarian Value Index ETF PVAL Stock Holding History

UBS Group’s Portfolio PVAL Stock Details PVAL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,611	Closed	-$37K	–	8784
2020 Q2	$37K	Sell	1,611 -315	-16%	-$6.8K	﹤0.01%	6130
2020 Q1	$37K	Buy	1,926 +1,916	+19,160%	+$47.3K	﹤0.01%	6074
2019 Q4	$0	Sell	10 -146	-94%	-$4.02K	﹤0.01%	8631
2019 Q3	$4K	Buy	+156	New	+$4.08K	﹤0.01%	7595
2019 Q2	–	Sell	-1	Closed	–	–	8362
2019 Q1	$0	Hold	1	–	–	﹤0.01%	8433
2018 Q4	$0	Buy	+1	New	+$26	﹤0.01%	8487
2018 Q3	–	Sell	-29	Closed	-$1K	–	8429
2018 Q2	$1K	Buy	29 +4	+16%	+$104	﹤0.01%	7880
2018 Q1	$1K	Buy	+25	New	+$655	﹤0.01%	7706

UBS Group's PVAL Position: Q3 2020 in Review

UBS Group sold out of Principal Contrarian Value Index ETF (PVAL) in Q3 2020, closing a stake of 1,611 shares — an estimated $37K sold.

UBS Group first reported a position in PVAL in Q1 2018 and held it in 8 quarters. The position peaked at $37K in Q2 2020. 0 funds tracked by Wall St. Rank hold PVAL as of Q3 2020.

UBS Group reported no remaining Principal Contrarian Value Index ETF position as of Q3 2020 after selling out during the quarter.
UBS Group sold 1,611 Principal Contrarian Value Index ETF shares in Q3 2020, an estimated $37K.
UBS Group first reported a position in Principal Contrarian Value Index ETF in Q1 2018 and held it in 8 quarters.
UBS Group's Principal Contrarian Value Index ETF position peaked at $37K in Q2 2020.
0 funds tracked by Wall St. Rank held Principal Contrarian Value Index ETF as of Q3 2020.

Based on UBS Group's 13F filing for Q3 2020, filed 12 Nov 2020.